Seeing Is Believing
Currently out of the existing stock ratings of Madison El-Saadi, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).
Analyst Madison El-Saadi, currently employed at B. RILEY, carries an average stock price target met ratio of 53% that have a potential upside of 59.26% achieved within 151 days.
Madison El-Saadi’s has documented 34 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VNDA, Vanda Pharmaceuticals at 09-Aug-2026.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 9/19/2024. The price target of $11 was fulfilled within 27 days with a profit of $5.06 (85.19%) receiving and performance score of 31.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Sep-2022
$316
$101.34 (47.21%)
$306
Buy Since 24-Jan-2024
$297
$82.34 (38.36%)
$304
Buy Since 02-Sep-2025
$256
$41.34 (19.26%)
$255
Buy Since 15-Oct-2019
$275
$60.34 (28.11%)
$260
Hold Since 04-May-2026
$251
$36.34 (16.93%)
$242
Which stock is Madison El-Saadi is most bullish on?
Which stock is Madison El-Saadi is most reserved on?
What Year was the first public recommendation made by Madison El-Saadi?